Skip to main content

Advertisement

Download PDF

Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England

BMC Cancer volume 8, Article number: 271 (2008) Cite this article

Abstract

Background

Cancer incidence varies by socioeconomic group and these variations have been linked with environmental and lifestyle factors, differences in access to health care and health seeking behaviour. Socioeconomic variations in cancer incidence by region and age are less clearly understood but they are crucial for targeting prevention measures and health care commissioning.

Methods

Data were obtained from all eight English cancer registries for patients diagnosed between 1998 and 2003, for all invasive cases of female breast cancer (ICD-10 code C50), lung cancer (ICD-10 codes C33-C34), cervical cancer (ICD-10 code C53), and malignant melanoma of the skin (ICD-10 code C43). Socioeconomic status was assigned to each patient based on their postcode of residence at diagnosis, using the income domain of the Index of Multiple Deprivation 2004. We analysed the socioeconomic variations in the incidence of breast, lung and cervical cancer and malignant melanoma of the skin for England, and regionally and by age.

Results

Incidence was highest for the most deprived patients for lung cancer and cervical cancer, whilst the opposite was observed for malignant melanoma and breast cancer. The difference in incidence between the most and the least deprived groups was higher for lung cancer patients aged under 65 at diagnosis than those over 65 at diagnosis, which may indicate a cohort effect. There were regional differences in the socioeconomic gradients with the gap being widest for lung and cervical cancer in the North (North East, North West and Yorkshire and Humberside) and for malignant melanoma in the East and South West. There were only modest variations in breast cancer incidence by region. If the incidence of lung and cervical cancer were decreased to that of the least deprived group it would prevent 36% of lung cancer cases in men, 38% of lung cancer cases in women and 28% of cervical cancer cases. Incidence of breast cancer and melanoma was highest in the least deprived group, therefore if all socioeconomic groups had incidence rates similar to the least deprived group it is estimated that the number of cases would increase by 7% for breast cancer, 27% for melanoma in men and 29% for melanoma in women.

Conclusion

National comparison of socioeconomic variations in cancer incidence by region and age can provide an unbiased basis for public health prevention and health commissioning. Decreasing inequalities in incidence requires the integration of information on risk factors, incidence and projected incidence but targeted public health interventions could help to reduce regional inequalities in incidence and reduce the future cancer burden.

Peer Review reports

Background

Incidence for many cancers varies by socioeconomic group in the UK [1–3] and other countries [4–6]. Socioeconomic variations have been attributed to environment [7], lifestyle [8, 9], biological effects [10], access to health care [11–17] and health seeking behaviour [18–21]. These variations are particularly wide for the cancers under study (breast, cervix, lung, malignant melanoma) due to the close association between socioeconomic status and risk factors. Inequalities in mortality[22] and survival [5, 23–30] have been evaluated to assess improvements in inequities in outcome and access to treatment. National comparison of socioeconomic variations in cancer incidence by region and age are less understood but provide an unbiased basis for prevention and commissioning. Previous studies have focused on regional variations [22, 31] with one recent study of regional and socioeconomic variation in breast and lung cancer[32], although this did not include age variations. This study aims to investigate socio-economic differences in breast, lung, cervical and malignant melanoma cancer incidence among patients diagnosed in England during 1998–2003, by region and age.

Methods

Data were obtained from all eight English cancer registries for patients diagnosed between 1998 and 2003, for all invasive cases of female breast cancer (ICD-10 code C50), lung cancer (ICD-10 codes C33-C34), cervical cancer (ICD-10 code C53), and malignant melanoma of the skin (ICD-10 code C43). These cancer sites were selected due to their association with risk factors closely linked to socioeconomic status, such as smoking, UV exposure, HPV infection and reproductive factors. Breast and cervical cancer were of specific interest due to socioeconomic variations in screening up-take.

A socioeconomic group was assigned to each patient based on their postcode of residence at diagnosis, using the income domain of the Index of Multiple Deprivation 2004 (IMD) [33]. IMD is a national measure of deprivation for each Lower Super Output Area in England based on information collected at census and in government databases, such as income support and job seekers allowance. IMD is based on seven domains of deprivation (income, employment, health deprivation and disability, education skills and training, barriers to housing and services, crime and living environment). To exclude the health related measures of the IMD, only the income domain of the IMD was used in this study. This has been shown to strongly correlated with deprivation and exclude health related measures [25, 34]. The national income domain of the IMD for all lower super output areas (LSOAs) in England was ranked in ascending order and divided into quintiles, each containing 20% of the total population of England [35], with quintile 1 being least deprived fifth of the population and quintile 5 the most deprived fifth of population. Super output areas are geographies that were introduced by the Office for National Statistics (ONS) in and attempt to create a uniform geographic system across England for analysis that stays stable over time. There are 32,482 lower super output areas (LSOAs) in England with an average population size of 1,500 residents [36].

European age-standardised incidence rates (ASRs) were calculated by deprivation quintile, cancer site, Government Office Region (GOR) (Figure 1), age group (under 65, 65 and over) and gender. Rate Ratios (RR) were calculated by region and age (under 65 and 65 and over) using the least deprived (quintile 1) as the baseline. The number (and percentage) of additional/fewer incident cases that would be expected if incidence rates in all deprivation groups was the same as those in the least deprived was estimated. The difference between the observed and expected number of cases for socioeconomic group was calculated to provide an estimate of the burden of cancer should these inequalities change. All analyses were done in EXCEL and STATA 8.0 [37].

Figure 1
figure1

Map of Regions in UK.

Full size image

This study was carried out in association with the United Kingdom association of Cancer Registries (UKACR) which collect and conduct cancer surveillance using the data they collect under Section 60 of the Health and Social Care Act 2002. The study used an anonymised dataset and separate ethical approval was not required.

Results

The highest incidence rates in England occurred in the most deprived groups for both lung cancer and cervical cancer, while the opposite was the case for malignant melanoma and breast cancer with the least deprived groups having the highest incidence (Table 1). The inequality between the least deprived, and the most deprived was highest for lung cancer in men (RR 2.53 95% CI: 2.48–2.58) and women (RR 2.73 95% CI: 2.66–2.80). Similarly, cervical cancer incidence was highest in the most deprived group (RR 2.08 95% CI: 1.97–2.19) and decreased consistently with increasing affluence. If all population groups has the same incidence rates as the least deprived group, we would expect 41,076 (36%) fewer lung cancer cases in men, 28,148 (38%) fewer cases in women and 4,108 (28%) fewer cervical cancer cases. Breast cancer incidence was highest in the least deprived with modest differences between socioeconomic groups (Breast: RR 0.84 95% CI: 0.82–0.85). Malignant melanoma incidence showed wide variations by socioeconomic status but similar trends for men and women (Melanoma in men: RR 0.49 95% CI: 0.47–0.52, Melanoma in women: RR 0.48 95% CI: 0.46–0.51). If the socioeconomic-specific incidence rates where equal to those in the least deprived quintile across all population groups the number of breast cancer cases would rise by 15,496 (7%) and cases of malignant melanoma of the skin would increase by 4,286 (27%) in men and 5,862 (29%) in women.

Table 1 Incidence by socioeconomic status for lung, breast, cervical, and melanoma cancer, England, 1998–2003
Full size table

There were only modest differences in socioeconomic-specific breast cancer incidence rates both between and within regions, with the highest in the East Midlands (RR 0.89 95% CI 0.85–0.94) and the lowest in London (RR 0.79 95% CI 0.76–0.83) (Figure 2). Socioeconomic variations by age were small and not significantly different for women aged under 65 and over 65 (Figure 3).

Figure 2
figure2

Breast cancer incidence (European age-standardised rate per 100,000) by Government Office Region, England, 1998–2003.

Full size image
Figure 3
figure3

Rate ratio for cancer incidence for patients in least to most deprived socioeconomic group, England, 1998–2003.

Full size image

Cervical cancer incidence varied substantially within regions by socioeconomic group with a large increase in incidence occurring between the second and the most deprived group in most regions, except London and the East of England. This difference was most significant in the South West with an age standardised incidence rate of 10.3 per 100,000 (95% CI: 9.1–11.5) in the second most deprived and 15.5 per 100,000 (95% CI: 13.3–17.7) in the most deprived group. Socioeconomic-specific incidence rates in general, as well as the difference between the most and least deprived were lowest in London and the East of England. In contrast the highest incidence rates were recorded in deprived groups in the North West and South West. The gap between most and least deprived was greatest in the North West and Yorkshire and Humberside. The deprivation gap was not statistically different between those under 65 and 65 and over.

Incidence rates for lung cancer were 40% lower in women than men however the trends by age and regional were still similar. The highest incidence rates occurred in the most deprived group for both men and women in the North East and North West, with the lowest occurring in the East of England (Figure 2). The North East and West Midlands had the highest deprivation gap in men, with the North West and North East having the highest for women. Lung cancer was the only site with a significant difference in the deprivation gap by age group with those aged under 65 having a higher gap (men: RR 3.29 95% CI: 3.16–3.41, women: RR 3.18 95% CI 3.03–3.34) than those age 65 and over (men: RR 2.26 95% CI 2.20–2.30 and women: RR 2.29 95% CI 2.42–2.56) (Figure 4).

Figure 4
figure4

Lung cancer incidence in men (European age-standardised rate per 100,000) by Government Office Region, England, 1998-2003.

Full size image

The deprivation gap for malignant melanoma was similar in men and women, with the exception of the North East where it was larger in men, and the South West, where it is larger in women. Incidence was higher for each socioeconomic group and the deprivation gap narrower in the South West than in other regions, for both men (RR 0.84 95% CI: 0.70–1.00) and women (RR 0.69 95% CI: 0.58–0.81). In the North East there was some inconsistency in socioeconomic-specific incidence for malignant melanoma as incidence in the second least deprived group had lower incidence than the socioeconomic groups on either side. London had the lowest incidence for all deprivation groups, in men and women. The largest difference between least and most deprived occurred in West Midlands for men (RR 0.43 95% CI: 0.36–0.51) and Yorkshire and Humber for women (RR 0.38 95% CI: 0.32–0.44).

Discussion

Socioeconomic variations in cancer are of interest to inform public health prevention and health care planning, particularly in developing programmes to reduce inequalities in health, for which there are key targets in England [38, 38]. While survival and mortality can be influence in the short term cancer incidence requires the latent period before any impacts can be evaluated. Despite this lag time evaluations of cancer, particularly by age, region and deprivation, can assist in public health planning and targeted prevention.

Women in the least deprived socioeconomic groups have higher breast cancer incidence which has been attributed to the association of socioeconomic status with reproductive factors [39] and has been seen in other studies [4, 40]. Women from a less deprived socioeconomic group may be more likely to have their first child at a later age, have fewer children in their lifetime and take hormone replacement therapy, with each of these factors associated with increased breast cancer incidence [39–41]. Breast cancer is associated with obesity in post-menopausal women, with the association particularly strong for deprived women [42]. Deprived women have lower levels of screening up-take to the national mammographic screening programme for 50 to 65 year olds (extended to 65 to 69 in 2007) [43–45], however there was little variation by socioeconomic status. The constancy across regions and socioeconomic status may possibly be due to high awareness among all groups. The moderate variations in breast cancer incidence and deprivation gap across regions was consistent with other studies by region and socioeconomic status, with the socioeconomic differences in incidence remaining constant for most regions over time [32]. A Scottish study of inequalities in breast cancer survival found the despite differential screening up-take inequalities in survival had narrowed in the screening ages since the implementation of the screening programme [46].

Cervical cancer screening began nationally in England in 1988 for women aged 20 to 65 years but the age at first screening invitation was raised to 25 years in 2005 [47]. Screening detects dysplastic lesions and in situ (CIN III) tumours that are then removed prior to developing into invasive cervical cancer. Most cervical cancers develop as a result of Human Papilloma Virus (HPV), an asymptomatic sexually transmitted infection which is carcinogenic. HPV infection is associated with younger age and higher number of partners [48–50], after adjusting for these factors socioeconomic status was associated with HPV infection in some studies [48, 49] while others found no significant association [50]. Screening up-take has been reported to vary by socioeconomic status [51] and be lower for women with low levels of education in England [52]. The lower incidence rates of cervical cancer for Southern England (East, South West, London and South East) are consistent with other national studies [31]. Socioeconomic-variations in screening up-take contribute to the regional variations in deprivation gap, although the regional variations and influence of HPV infection (and associated risk factors) remains an area for further study.

The high lung cancer incidence and deprivation gap in this study is consistent with other studies [31, 32]. Smoking is strongly associated with socioeconomic status with over 80% of lung cancer cases are estimated to be attributable to smoking [53, 54]. Smoking prevalence rapid decreased during the 1970s and 1980s, with larger decreases occurring in the non-manual groups [55] which is consistent with an increase in the deprivation differences found in other studies [32]. Smoking prevalence in 2006 was higher in the manual occupational groups (27%) than the non-manual groups (17%)[56]. Manual groups were also associated with higher tobacco consumption and beginning smoking at an earlier age [56]. Smoking prevalence by socioeconomic status is not currently available. While occupational and socioeconomic status can not be directly compared evidence suggests that the manual occupational groups are more similar to the more deprived, than the least deprived.

The large deprivation-specific differences found in incidence rates for patients diagnosed with lung cancer under 65, may indicate a cohort effect. In contrast to older ages where rapid decreases in smoking occurred during the 1970s and 1980s there have been larger decreases in the proportion of young men smoking than young women [55, 56]. A large cross-sectional study of socioeconomic gradients in smoking among young women in Southampton, England found the prevalence of smoking was highest among the most deprived [57] with the socioeconomic differences increasing with age, as smoking cessation was more common in the least deprived. These trends may suggest a cohort effect with continuing inequalities in lung cancer incidence by age, continued monitoring of smoking prevalence is key to assessing these. In June 2007 a national smoking ban in enclosed public spaces was introduced, it remains to be seen if this will decrease smoking prevalence and/or tobacco consumption.

Incidence of malignant melanoma of the skin in England is expected to increase by 88% in men (66% in women) by 2020 [58], with regional variations in these increases [59]. Regional variations in skin cancer have also been seen in other countries with variations attributed to UV exposure and opportunities for recreational exposure [60–62]. Within the UK the South West receives the most UV exposure [49] and also has an older population with both contributing to the high incidence of malignant melanoma. Exposure to UV has increasingly occurred through sun bed use and holidays abroad which are both significantly associated with malignant melanoma [60]. Higher incidence in the least deprived and regional variations may be largely explained by holidays abroad and exposure to natural UV, however current UV exposure highlights changes to these trends. It is difficult to estimate sun bed use as most are private and unregulated however, anecdotal evidence suggests that sun bed use is increasing in England particularly for teenagers and young adults and may represents a cohort of individuals at higher risk in the future. Exposure to sunbeds before the age of 35 was increased the risk of malignant melanoma by 75% [63]. A study in Dundee, Scotland found the number of sun parlours has increased by up to 30% since 1998 and that 83% of the sun beds exceeded the European standard for UV(B) radiation levels [64]. There is increasing access to sun beds through private unmanned sun parlours, with sun parlours tending to be clustered in areas of deprivation [65]. The cohort of high risk individuals may represent a substantial burden of future skin cancer.

Cancer registries in England collect data to a national specification and have high levels of case ascertainment and consistency [66]. However, there is probably some regional variation due to differences in data collection and timeliness, although this is unlikely to explain the magnitude of differences. Completeness of registration information, such as treatment and stage is known to be less complete for deprived patients [67, 68]. These variations would only influence the results of this study if a patients' diagnosis date were changed, and even in this case very little impact would be expected due to grouping of years, however this is unlikely due to the high quality of registry data [66]. Ascertainment of lung and breast cancers are known to be high although [69] regional variations in ascertainment of malignant melanoma have been shown for the early 1990s [31, 70, 71] with late stage tumours more likely to be registered [72]. Increased use of hospital admission system data in the late 1990s and 2000s would be expected to improved ascertainment, although no direct comparison of this has been published.

Ecological measures of socioeconomic status have been widely used by population-based cancer registries [25, 34] and in the absence of individual measures of socioeconomic status are a pragmatic choice. As socioeconomic status is based on area of residence at diagnosis it may not necessarily be representative of every patient's current or historical socioeconomic group and the associated cancer risk factors. However, generally people living in the same area have similar levels of deprivation and have found to be robust over time [34]. This is particularly relevant for cancers where exposure to risk factors occurs years or decades before cancer diagnosis. Alternative measures of socioeconomic status based on individual level data, such as education, occupation or income are also frequently used although cancer registries do not routinely collect these.

Conclusion

In the long-term decreasing socioeconomic variations in incidence will have a substantial impact on the burden of cancer, for both incidence and mortality. Variations in regional lung and cervical cancer and malignant melanoma rates highlight variations in exposure to risk factors. Lung cancer trends identified larger inequalities in those under 65 at diagnosis, while there were substantial regional and age specific variations for malignant melanoma. Socioeconomic variations in survival can potentially be targeted more quickly while efforts to change incidence will take many years to show any beneficial impact however, in the long term, decreasing inequalities in incidence will also decrease mortality and decrease the number of incident cases.

Abbreviations

ICD-10:

International Classification of Diseases version 10

LSOA:

lower super output areas

IMD:

Index of Multiple Deprivation

GOR:

Government Office Region

HPV:

Human Papilloma Virus

CIN III:

Carcinoma in situ

UV:

Ultra Violet Radiation.

References

  1. 1.

    Quinn MJ, Babb PJ, Brock A, Kirby L, Jones J: Cancer trends in England and Wales 1950–1999. (Studies on Medical and Population Subjects). 2001, London, The Stationery Office, 66-

  2. 2.

    Scottish Executive Health Department: Cancer Scenarios: An aid to planning cancer services in Scotland in the next decade. 2001, Edinburgh, The Scottish Executive, Black R, Stockton D

  3. 3.

    West Midlands Cancer Intelligence Unit: Cancer and Deprivation 2002. 2003, Birmingham, West Midlands Cancer Intelligence Unit

  4. 4.

    Kogevinas M, Porta M: Socio-economic differences in cancer survival: a review of the evidence. Social Inequalities and Cancer. (IARC Scientific Publication No. 138). Edited by: Kogevinas M, Pearce N, Susser M, Boffetta P. 1997, Lyon: IARC, 177-206.

  5. 5.

    Singh GK, Miller BA, Hankey BF, Edwards BK: Area socioeconomic variations in the U.S.; cancer incidence, mortality, stage, treatment, and survival, 1975–1999. NCI Cancer Surveillance Monograph Series, Number 4. 2003, Bethesda, MD, National Cancer Institute

  6. 6.

    Ward E, Jemal A, Cokkinides V, Singh GP, Cardines C, Ghafoor A, et al: Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer Journal for Clinicians. 2004, 54: 78-93. 10.3322/canjclin.54.2.78.

  7. 7.

    Launoy G, Le Coutour X, Gignoux M, Pottier D, Dugleux G: Influence of rural environment on diagnosis, treatment, and prognosis of colorectal cancer. Journal of Epidemiology and Community Health. 1992, 46: 365-367. 10.1136/jech.46.4.365.

  8. 8.

    Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC: Associations of sedentary lifestyles, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Research. 1997, 57: 4787-4794.

  9. 9.

    Shohaimi S, Welch A, Bingham S, Luben R, Day N, Wareham N, et al: Residential area deprivation predicts fruit and vegetable consumption independently of individual educational level and occupational social class: a cross sectional population study in the Norfolk cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk). Journal of Epidemiology and Community Health. 2004, 58: 686-691. 10.1136/jech.2003.008490.

  10. 10.

    Brewster DH, Thomson CS, Hole DJ, Black RJ, Stroner PL, Gillis CR: Relation between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian and lung cancer: results from four national, population based studies. British Medical Journal. 2001, 322: 830-831. 10.1136/bmj.322.7290.830.

  11. 11.

    Jack RH, Gulliford MC, Ferguson J, Møller H: Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services?. British Journal of Cancer. 2003, 88: 1025-1031. 10.1038/sj.bjc.6600831.

  12. 12.

    Jack RH, Guillford MC, Ferguson J, Møller H: Explaining inequalities in access to treatment in lung cancer. Journal of Evaluation in Clinical Practice. 2006, 12: 573-582. 10.1111/j.1365-2753.2006.00644.x.

  13. 13.

    Pollock A, Vickers N: Deprivation and emergency admissions for cancers of colorectum, lung, and breast in south east England: ecological study. British Medical Journal. 1998, 317: 245-252.

  14. 14.

    Campbell NC, Elliot AM, Sharp L, Ritchie LD, Cassidy J, Little J: Impact of deprivation and rural residence on treatment of colorectal and lung cancer. British Journal of Cancer. 2002, 87: 585-590. 10.1038/sj.bjc.6600515.

  15. 15.

    Stefoski MJ, Haward RA, Johnston C, Sainsbury R, Forman D: Surgeon work load and survival from breast cancer. British Journal of Cancer. 2003, 89: 487-491. 10.1038/sj.bjc.6601148.

  16. 16.

    Gregor A, Thomson CS, Brewster DH, Stroner PL, Davidson J, Fergusson RJ: Management and survival of lung cancer patients diagnosed in 1995 in Scotland: results of a national, population-based study. Thorax. 2001, 56: 212-217. 10.1136/thorax.56.3.212.

  17. 17.

    Howard GCW, Thomson CS, Stroner PL, Goodman CM, Windsor PW, Brewster DH: Patterns of referral, management and survival of patients diagnosed with prostate cancer in Scotland during 1988 and 1993: results of a national, retrospective population-based audit. British Journal of Urology. 2001, 87: 339-247.

  18. 18.

    Neal RD, Allgar VL: Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the 'National Survey of NHS Patients: Cancer'. British Journal of Cancer. 2005, 92: 1971-1975. 10.1038/sj.bjc.6602623.

  19. 19.

    Corner J, Hopkinson J, Roffe L: Experience of health changes and reasons for delay in seeking care: A UK study of the months prior to the diagnosis of lung cancer. Social Science & Medicine. 2006, 62: 1381-1391. 10.1016/j.socscimed.2005.08.012.

  20. 20.

    Smith LK, Pope C, Batha JL: Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet. 2005, 366: 825-831. 10.1016/S0140-6736(05)67030-4.

  21. 21.

    MacLeod U, Ross R, Twelves C, George WD, Gillis C, Watt GCM: Primary and secondary care management of women with early breast cancer from affluent and deprived areas: retrospective review of hospital and general practice records. British Medical Journal. 2000, 320: 1442-1445. 10.1136/bmj.320.7247.1442.

  22. 22.

    Griffiths C, Fitzpatrick J: Geographic variations in Health (Decennial Supplements No. 16). 2001, London, The Stationery office

  23. 23.

    Thomson CS, Hole D, Twelves CJ, Brewster DH, Black R, on behalf of the Scottish Cancer Therapy Network: Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. Journal of Epidemiology and Community Health. 2001, 55: 315-10.1136/jech.55.5.308.

  24. 24.

    Coleman MP, Babb P, Damiecki P, Grosclaude P, Honjo S, Jones J, et al: Cancer survival trends in England and Wales, 1971–1995: deprivation and NHS Region. (Studies in Medical and Population Subjects No. 61). 1999, London, The Stationery Office

  25. 25.

    Coleman MP, Rachet B, Woods LM, Mitry E, Riga M, Cooper N, et al: Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. British Journal of Cancer. 2004, 90: 1367-1373. 10.1038/sj.bjc.6601696.

  26. 26.

    Woods LM, Rachet B, Coleman MP: Origins of socio-economic inequalities in cancer survival: a review. Annals of Oncology. 2006, 17: 5-19. 10.1093/annonc/mdj007.

  27. 27.

    Schrijvers C, Mackenbach JP, Lutz J-M, Quinn M, Coleman MP: Deprivation, stage at diagnosis and cancer survival. International Journal of Cancer. 1995, 63: 324-329. 10.1002/ijc.2910630303.

  28. 28.

    Whynes DK, Frew EJ, Manghan CM, Scholefield JH, Hardcastle JD: Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Public Health. 2003, 117: 389-395. 10.1016/S0033-3506(03)00146-X.

  29. 29.

    Vercelli M, Lillini R, Capocaccia R, Micheli A, Coebergh J, Quinn M, et al: Cancer survival in the elderly: Effects of socio-economic factors and health care system features (ELDCARE project). European Journal of Cancer. 2006, 42: 234-242. 10.1016/j.ejca.2005.07.032.

  30. 30.

    Thomson CS, Brewster DH, Dewar JA, Twelves CJ: Improvement in survival for women with breast cancer in Scotland between 1987 and 1993: impact of earlier diagnosis and changes in treatment. European Journal of Cancer. 2004, 40: 743-753. 10.1016/j.ejca.2003.08.029.

  31. 31.

    Quinn M, Wood H, Cooper N, Rowan S: Cancer atlas of the United Kingdom and Ireland 1991–2000. (Studies on Medical and Population subjects No. 68). 2005, London, The Stationery Office

  32. 32.

    Rowan S: Trends in cancer incidence by deprivation, England and Wales, 1990–2002. Health Statistics Quarterly. 2007, Winter 2007: 24-35.

  33. 33.

    Neighbourhood Renewal Unit: The English Indices of deprivation 2004: Summary (revised). 2004, London, Office of the Deputy Prime Minister

  34. 34.

    Woods LM, Rachet B, Coleman MP: Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. British Journal of Cancer. 2005, 92: 1279-1282. 10.1038/sj.bjc.6602506.

  35. 35.

    ONS. Census 2001. ONS 8-3-2006. ONS. 1-9-2006.

  36. 36.

    Neighbourhood Renewal Unit Office of the DPM: The English Indices of Deprivation 2004 (Revised). 2004, London, ODPM

  37. 37.

    Statacorp: STATA statistical software. [8.0]. 2004, College Station, TX, Stata Corporation

  38. 38.

    Department of Health: The NHS Cancer Plan. 2000, London, Department of Health

  39. 39.

    Kawachi I, Kroenke C: Socioeconomic disparities in cancer incidence and mortality. Cancer epidemiology and prevention. Edited by: Schottenfeld D, Fraumeni JF Jr. 2006, Oxford: Oxford University Press, 174-188.

  40. 40.

    Downing A, Prakash K, Gilthorpe MS, Stefoski MJ, Forman D: The effect of socioeconomic background on stage at diagnosis, treatment pattern and survival in women with invasive breast cancer. British Journal of Cancer. 2007, 96: 836-840. 10.1038/sj.bjc.6603622.

  41. 41.

    Ma H, Berstein L, Pike MC, Ursin G: Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor stauts: a meta-analysis for epidemiological studies. Breast Cancer Research. 2006, 8: R43-10.1186/bcr1525.

  42. 42.

    Carmicheal AR: Obesity and prognosis of breast cancer. Obesity Review. 2006, 7: 333-340. 10.1111/j.1467-789X.2006.00261.x.

  43. 43.

    Maheswaran R, Pearson T, Jordan H, Black D: Socioeconomic deprivation, travel distance, location of service, and uptake of breast cancer screening in North Derbyshire, UK. Journal of Epidemiology and Community Health. 2006, 60: 208-212. 10.1136/jech.200X.038398.

  44. 44.

    Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, et al: Comparison of various characteristic of women who do and do not attend for breast cancer screening. Breast Cancer Research. 2002, 4: R1-10.1186/bcr418.

  45. 45.

    NHS: NHS breast screening programme. 2007, 20-4-2007, [http://www.cancerscreening.nhs.uk/breastscreen]

  46. 46.

    Shack LG, Rachet B, Brewster DH, Coleman MP: Socioeconomic inequalities in cancer survival in Scotland 1986–2000. British Journal of Cancer. 2007, 97: 999-1004.

  47. 47.

    NHS: NHS cervical screening programme. 2007, 4-4-2007, [http://www.cancerscreening.nhs.uk/cervical]

  48. 48.

    Muñoz N, Kato I, Bosch FX, Eluf-Neto J, De Sanjosé S, Ascunce N, et al: Risk factors for HPV DNA detection in middle-age women. Sexually Transmitted Diseases. 1996, 23: 504-510.

  49. 49.

    Kahn JA, Lan D, Khan RS: Sociodemographic factors associated with high-risk human papillomavirus infection. Obstetrics and Gynecology. 2007, 110: 87-95.

  50. 50.

    Khan MJ, Partridge EE, Wang SS, Schiffman M: Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer. 2005, 104: 61-70. 10.1002/cncr.21129.

  51. 51.

    Baker D, Middleton E: Cervical screening and health inequality in England in the 1990s. Journal of Community Health. 2003, 57: 417-423.

  52. 52.

    Sutton S, Rutherford C: Sociodemographic and attitudinal correlates of cervical screening uptake in a national sample of women in Britain. Social Science & Medicine. 2006, 61: 2460-2465. 10.1016/j.socscimed.2005.07.017.

  53. 53.

    Mohan J, Twigg L, Barnard S, Jones K: Social capital, geography and health: a small-area analysis for England. Social Science & Medicine. 2005, 60: 1267-1283. 10.1016/j.socscimed.2004.06.050.

  54. 54.

    Blot WJ, Fraumeni JR: Cancers of the lung and pleura. Cancer Epidemiology and Prevention. Edited by: Schottenfeld D, Faumeni JF Jr. 1996, New York: Oxford University Press, 637-665.

  55. 55.

    Rickards L, Fox K, Roberts C, Fletcher L, Goddard E: Living in Britian (Results from the 2002 General Household Survey No 31). 2004, London, The Stationary Office

  56. 56.

    Ali R, Greer J, Matthews D, Murray L, Robinson S, Sattar G: General Household Survey 2006. 2006, Newport, Office for National Statistics

  57. 57.

    Harman J, Graham H, Francis B, Inskip HM, SWS Study Group: Socioeconomic gradients in smoking among young women: A British survey. Social Science & Medicine. 2006, 63: 2791-2800. 10.1016/j.socscimed.2006.07.021.

  58. 58.

    Møller H, Fairley L, Coupland V, Okello C, Green M, Forman D, et al: The future burden of cancer in England: incidence and numbers of new patients in 2020. British Journal of Cancer. 2007, 96: 1484-1488. 10.1038/sj.bjc.6603746.

  59. 59.

    Shack LG, Khan S, Moran A: Cancer incidence projections in the North West. 2007, Manchester, NWCIS

  60. 60.

    Bentham G, Aase A: Incidence of malignant melanoma of the skin in Norway 1955–1989: associations with solare ultraviolet radiation, income and holidays abroad. International Journal of Epidemiology. 1996, 25: 1132-1138. 10.1093/ije/25.6.1132.

  61. 61.

    Abarca JF, Casiccia CC: Skin cancer and ultraviolet-B radiation under the Antarctic ozone hole: southern Chile, 1987–2000. Photodermatology, photoimmunology & photomedicine. 2002, 18: 294-302. 10.1034/j.1600-0781.2002.02782.x.

  62. 62.

    de Vries E, Schouten LJ, Visser O, Eggermont AM, Coebergh JW, Working Group of Regional Cancer Registries: Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient?. European Journal of Cancer. 2003, 39: 1439-1446. 10.1016/S0959-8049(03)00320-4.

  63. 63.

    International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer: The association of use of sunbes with cutaneous malignant melanoma and other skin cancers: A systamatic review. International Journal of Cancer. 2007, 120: 1116-1122. 10.1002/ijc.22453.

  64. 64.

    Oliver H, Ferguson J, Moseley H: Quantitative risk assessment of sunbeds: impact of new high power lamps. British Journal of Dermatology. 2007, 157: 215-216. 10.1111/j.1365-2133.2007.07985.x.

  65. 65.

    Cancer Research UK: Sunbed Symposium Executive Summary. London.

  66. 66.

    Hugget C: Nationwide audit of the quality and comparability of data held by regional cancer registries. 1995, Bristol, University of Bristol

  67. 67.

    Adams J, White M, Forman D: Are there socioeconomic gradients in the quality of data held by registries?. Journal of Epidemiology and Community Health. 2004, 58: 1052-1053. 10.1136/jech.2004.020008.

  68. 68.

    Adams J, White M, Forman D: Are there socioeconomic gradients in stage and grade of breast cancer at diagnosis? Cross sectional analysis of UK cancer registry data. British Medical Journal. 2004, 329: 142-143. 10.1136/bmj.38114.679387.AE.

  69. 69.

    Thomson C, on behalf of the Quality Assurance Group of the UK Association of Cancer Registries: Annual Performance Indicators Report, 2006. 2006, Birmingham, UKACR

  70. 70.

    NYCRIS: Cancer treatment policies & their effects on survival; colorectal. 2000, Leeds, NYCRIS. Key sites study

  71. 71.

    Stefoski MJ, Johnston C, Adamson P, Wright D, Newton Bishop JA, Batman P: How complete has skin cancer registration been in the UK? – a study from Yorkshire. European Journal of Cancer. 2003, 12: 125-133. 10.1097/00008469-200304000-00006.

  72. 72.

    Melia J, Frost T, Graham-Brown R, Hunter J, Marsden A, du Viver A, et al: Problems with registration of cutaneous malignant melanoma in England. British Journal of Cancer. 1995, 72: 224-228.

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/8/271/prepub

Download references

Acknowledgements

This study was supported by UK Association of Cancer Registries and its constituent cancer registries for whom the authors were employed. The authors would like to thank the UKACR for data collection, study design, comments on the draft and decision to submit. The authors would also like to thank Lucy Boyd, Epidemiologist at Cancer Research UK for providing some of the references and Holger Möller, Intelligence Project Officer at NWCIS for his comments.

Author information

Affiliations

  1. North West Cancer Intelligence Service, Christie Hospital NHS Trust, Kinnaird Road, Withington, Manchester, M20 4QL, UK
    • Lorraine Shack
  2. Non-communicable Disease and Epidemiology Unit, London School of Hygiene and Tropical Medicine, WC1E 7HT, UK
    • Lorraine Shack
    •  & Henrik Møller
  3. Trent Cancer Registry, 5 Old Fulwood Road, Sheffield, S10 3TG, UK
    • Catrina Jordan
  4. Cancer Research UK, London, WC2A 3PX, UK
    • Catherine S Thomson
  5. King's College London, Thames Cancer Registry, 1st Floor, Capital House, 42 Weston Street, London, SE1 3QD, UK
    • Vivian Mak
    •  & Henrik Møller
Authors
  1. Lorraine Shack
    View author publications
    You can also search for this author in
  2. Catrina Jordan
    View author publications
    You can also search for this author in
  3. Catherine S Thomson
    View author publications
    You can also search for this author in
  4. Vivian Mak
    View author publications
    You can also search for this author in
  5. Henrik Møller
    View author publications
    You can also search for this author in

Consortia

UK Association of Cancer Registries

Corresponding author

Correspondence to Lorraine Shack.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CJ, CT, LS, HM and VM were involved in the study design with the statistical analysis carried out by CJ and LS. LS wrote the draft of the manuscript to which all authors subsequently contributed. All authors contributed to the interpretation of results and revision and approval of the final manuscript.

Authors’ original submitted files for images

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Shack, L., Jordan, C., Thomson, C.S. et al. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer 8, 271 (2008). https://doi.org/10.1186/1471-2407-8-271

Download citation

Keywords

  • Cervical Cancer
  • Rate Ratio
  • Smoking Prevalence
  • Breast Cancer Incidence
  • Socioeconomic Group

Comments

BMC Cancer

ISSN: 1471-2407

Contact us